Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. - Shivapurkar, Narayan; Gay, Martha D.; He, Aiwu; Chen, Wenqiang; Golnazar, Shermineh; Cao, Hong; Duka, Tetyana; Kallakury, Bhaskar; Vasudevan, Sona; Smith, Jill P. (International Journal of Molecular Sciences, 2023)